AIM Vaccine Revenue

In the year 2025, AIM Vaccine had annual revenue of 1.17B CNY, down -9.29%. AIM Vaccine had revenue of 651.02M in the half year ending December 31, 2025, with 0.62% growth.

Revenue

1.17B CNY

Revenue Growth

-9.29%

P/S Ratio

2.36

Revenue / Employee

795.14K CNY

Employees

1,466

Market Cap

3.07B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.17B	-119.36M	-9.29%
Dec 31, 2024	1.29B	97.56M	8.22%
Dec 31, 2023	1.19B	-76.61M	-6.06%
Dec 31, 2022	1.26B	-306.06M	-19.49%
Dec 31, 2021	1.57B	-67.84M	-4.14%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Recbio Technology	14.16M
Medtide	634.40M
Antengene Corporation	117.22M
BioDlink International Company	831.99M
Viva Biotech Holdings	1.92B
Mirxes Holding Company	166.32M
Clover Biopharmaceuticals	3.90M
TYK Medicines	117.25K

Revenue Rankings